121 related articles for article (PubMed ID: 31578465)
1. Hematopoietic cell transplant nurse coordinators' perceptions of related donor care: a European survey from the EBMT Nurses Group.
Polomeni A; Bompoint C; Labopin M; Badoglio M; Battipaglia G; Eeltink C; Liptrott SJ; Babik A; Murray J; Stringer J
Bone Marrow Transplant; 2020 Mar; 55(3):623-632. PubMed ID: 31578465
[TBL] [Abstract][Full Text] [Related]
2. Current practices for screening, consent and care of related donors in France: Haematopoietic stem cell transplantation coordinator nurses' perceptions.
Polomeni A; Bompoint C; Gomez A; Brissot E; Ruggeri A; Belhocine R; Mohty M
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27922202
[TBL] [Abstract][Full Text] [Related]
3. Adult related haematopoietic stem cell donor care: Views of Transplant Nurses.
Zomerdijk N; Turner J; Hill GR; Gottlieb D
Eur J Oncol Nurs; 2019 Aug; 41():56-63. PubMed ID: 31358258
[TBL] [Abstract][Full Text] [Related]
4. Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.
Pidala J; Mupfudze TG; Payton T; Barker J; Perales MA; Shaw BE; Fernández-Viña M; Burns LJ; Dehn J
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2501-2506. PubMed ID: 31419569
[TBL] [Abstract][Full Text] [Related]
5. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.
Ghosh N; Karmali R; Rocha V; Ahn KW; DiGilio A; Hari PN; Bachanova V; Bacher U; Dahi P; de Lima M; D'Souza A; Fenske TS; Ganguly S; Kharfan-Dabaja MA; Prestidge TD; Savani BN; Smith SM; Sureda AM; Waller EK; Jaglowski S; Herrera AF; Armand P; Salit RB; Wagner-Johnston ND; Fuchs E; Bolaños-Meade J; Hamadani M
J Clin Oncol; 2016 Sep; 34(26):3141-9. PubMed ID: 27269951
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?
Nishiwaki S; Atsuta Y; Tanaka J
Bone Marrow Transplant; 2013 Nov; 48(11):1369-76. PubMed ID: 23474804
[TBL] [Abstract][Full Text] [Related]
7. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
Segal E; Martens M; Wang HL; Brazauskas R; Weisdorf D; Sandmaier BM; Khoury HJ; de Lima M; Saber W
Cancer; 2017 Sep; 123(17):3346-3355. PubMed ID: 28452054
[TBL] [Abstract][Full Text] [Related]
8. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
Kindwall-Keller TL; Ballen KK
Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
[TBL] [Abstract][Full Text] [Related]
9. European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards.
Anthias C; O'Donnell PV; Kiefer DM; Yared J; Norkin M; Anderlini P; Savani BN; Diaz MA; Bitan M; Halter JP; Logan BR; Switzer GE; Pulsipher MA; Confer DL; Shaw BE
Biol Blood Marrow Transplant; 2016 Mar; 22(3):514-9. PubMed ID: 26597079
[TBL] [Abstract][Full Text] [Related]
10. Contribution of nurses to protective environment in haematopoietic cell transplant setting: an international survey by the European Society for Blood and Marrow Transplantation.
Agreiter I; Kozijn AE; Bakunina K; Averbuch D; Stringer J; Hutt D; Mikulska M; Bögel TN; Canesi M; Cloutman-Green E; Bosman PV; Gil L; Liptrott SJ; Murray J; Styczynski J;
Bone Marrow Transplant; 2021 Jun; 56(6):1433-1440. PubMed ID: 33514921
[TBL] [Abstract][Full Text] [Related]
11. Outcomes from unrelated donor hematopoietic stem cell transplantation.
Perez LE
Cancer Control; 2011 Oct; 18(4):216-21. PubMed ID: 21976240
[TBL] [Abstract][Full Text] [Related]
12. Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.
Anthias C; Shaw BE; Kiefer DM; Liesveld JL; Yared J; Kamble RT; D'Souza A; Hematti P; Seftel MD; Norkin M; DeFilipp Z; Kasow KA; Abidi MH; Savani BN; Shah NN; Anderlini P; Diaz MA; Malone AK; Halter JP; Lazarus HM; Logan BR; Switzer GE; Pulsipher MA; Confer DL; O'Donnell PV
Biol Blood Marrow Transplant; 2016 Mar; 22(3):520-7. PubMed ID: 26597080
[TBL] [Abstract][Full Text] [Related]
13. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.
Barba P; Martino R; Pérez-Simón JA; Fernández-Avilés F; Castillo N; Piñana JL; López-Anglada L; Rovira M; Bosch F; Carreras E; Corral LL; Sierra J; Valcárcel D
Biol Blood Marrow Transplant; 2014 Jan; 20(1):66-72. PubMed ID: 24141006
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. HLA typing and haematopoietic stem cell transplantation in the histocompatibility unit of the Ibn Sina University Hospital in Rabat (Morocco).
Brick C; Atouf O; Ouadghiri S; Drissi Bourhanbour A; Bougar S; Yakhlef I; Essakalli M
Transfus Clin Biol; 2019 Nov; 26(4):293-298. PubMed ID: 30366818
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
17. [A comparison of the therapeutic effects between related donor and unrelated donor allogeneic hematopoietic stem cell transplantation in treatment of leukemia].
Yang K; Liu QF; Fan ZP; Sun J; Xu D; Wei YQ; Zhang Y; Meng FY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):135-9. PubMed ID: 17445441
[TBL] [Abstract][Full Text] [Related]
18. Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.
Bitan M; van Walraven SM; Worel N; Ball LM; Styczynski J; Torrabadella M; Witt V; Shaw BE; Seber A; Yabe H; Greinix HT; Peters C; Gluckman E; Rocha V; Halter J; Pulsipher MA
Biol Blood Marrow Transplant; 2016 Jan; 22(1):96-103. PubMed ID: 26307344
[TBL] [Abstract][Full Text] [Related]
19. Impact of transplant eligibility and availability of a human leukocyte antigen-identical matched related donor on outcome of older patients with acute lymphoblastic leukemia.
Barba P; Martino R; Martinez-Cuadron D; Olga G; Esquirol A; Gil-Cortés C; Gonzalez J; Fernandez-Avilés F; Valcárcel D; Guardia R; Duarte RF; Hernandez-Rivas JM; Abella E; Montesinos P; Ribera JM
Leuk Lymphoma; 2015; 56(10):2812-8. PubMed ID: 25686647
[TBL] [Abstract][Full Text] [Related]
20. Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell Disease.
Nickel RS; Kamani NR
Biol Blood Marrow Transplant; 2018 Feb; 24(2):219-227. PubMed ID: 28870775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
